Mark Sawicki - Mar 22, 2023 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Role
Chief Scientific Officer
Signature
/s/ Mark Sawicki
Stock symbol
CYRX
Transactions as of
Mar 22, 2023
Transactions value $
$0
Form type
4
Date filed
3/24/2023, 06:00 PM
Previous filing
Mar 17, 2023
Next filing
Sep 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYRX Common Stock Award $0 +10.5K +16.95% $0.00 72.1K Mar 22, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYRX Stock Option (right to buy) Award $0 +20.9K $0.00 20.9K Mar 22, 2023 Common Stock 20.9K $23.78 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024.
F2 1/48 of options vest on the 22nd of each month for forty-eight months beginning 4/22/2023.